Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE
Go back to Arrowhead Pharmaceuticals Presents Preclinical Data on New RNAi-Based Obesity Program ARO-INHBE| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 86.97 +0.42 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.55 | 52 Week High | $8.22 | |||
| Open | $87.28 | 52 Week Low | $3.07 | |||
| Day High | $87.57 | P/E | N/A | |||
| Day Low | $83.79 | EPS | $-1.30 | |||
| Volume | 1,914,946 | |||||
